...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review.
【24h】

Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review.

机译:隆突性皮肤纤维肉瘤:在单个机构中接受文献复习的16例患者的病例系列。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Dermatofibrosarcoma protuberans is an uncommon skin tumour with a low to intermediate-grade of malignancy, characterized by progressive growth and a propensity for local recurrence. PATIENTS AND METHODS: A retrospective study of a series of 16 consecutive patients with dermatofibrosarcoma protuberans who were treated in the host Institution over the last seven years was performed, with special emphasis on the outcome and disease-free interval, as well as recurrence rate over a mean follow-up period of 43.65 months. RESULTS: The clinicopathological features and results were reviewed. The primary treatment consisted of wide local excision with or without radiotherapy on 13 patients with primary and 3 with recurrent disease, and all patients remained free of disease recurrence during the mean follow-up period. CONCLUSION: The results of this study and a review of the literature support the notion that aggressive, wide surgical resection with disease-free margins, with or without radiotherapy decreases local recurrences and offers an excellent probability of cure. The accumulated data also confirm that all patients with dermatofibrosarcoma protuberans should be followed up for an extended period, beyond the usual recommended 5-year follow-up, because late recurrences may occur.
机译:背景:隆突性皮肤皮肤肉瘤是一种罕见的皮肤肿瘤,恶性程度低至中度,其特征在于进行性生长和局部复发的倾向。患者与方法:回顾性研究了过去七年在宿主机构中接受治疗的连续16例皮肤纤维肉瘤隆突患者的系列情况,特别侧重于结局和无病间隔以及复发率。平均随访期为43.65个月。结果:回顾了临床病理特征和结果。初级治疗包括对13例原发性和3例复发性疾病的患者进行广泛的局部切除,无论是否接受放疗,所有患者在平均随访期间均未复发。结论:这项研究的结果和文献综述支持以下观点:积极的,广泛的,无病切缘的手术切除,无论是否进行放疗,均会降低局部复发率,并具有极高的治愈率。累积的数据还证实,所有皮肤隆突性皮肤纤维肉瘤患者均应进行长期随访,超过通常建议的5年随访,因为这可能会导致晚期复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号